Quest Diagnostics Says Unauthorized Party Reached Patient Records In Quanum LSM Client System
An 8-K says Quest learned of the access Wednesday, called in federal law enforcement and says operations were not materially disrupted.
Quest Diagnostics believes an unauthorized party accessed certain patient records through its Quanum LSM system, the company said in an 8-K filed Thursday. The lab testing company says it learned of the intrusion on Wednesday.
What the 8-K says
Quanum LSM is the system certain Quest clients use to place test orders and to receive and look up results. The filing, an Item 8.01 report of "other events," puts the date of the earliest event at October 21, 2026, which was Wednesday.
Quest said it promptly started its cybersecurity incident response procedures. The stated aims were to contain the activity, assess the nature and scope of the incident, and put appropriate remedial measures in place.
The company has notified federal law enforcement authorities and engaged external cybersecurity experts to help with the investigation and response, according to the filing.
Quest was careful about scope. "While the full scope of unauthorized access remains under investigation," the filing says, the company believes at this time that an unauthorized party accessed certain patient records. It does not say how many records were reached or whose they were.
What it changes
The filing says the incident "has not materially disrupted the Company's business operations or its ability to serve patients." On the company's account, testing and patient service are continuing.
The risk language in the filing now lists "the impact of the incident described in this report" among the factors that could affect Quest's future results. The filing does not put a cost or a financial estimate on the incident.
For holders, the open question is scale. DGX shares closed at $238.93 on Wednesday, before the filing became public Thursday morning, so that price does not reflect the disclosure.
Sean D. Mersten, Quest's vice president and corporate secretary, signed the report on October 22, 2026.
What to watch
Quest's investigation is ongoing. Any further finding on the number of patient records accessed, and whose they were, would set the size of the incident and would come through a later company disclosure.
The 8-K gives the facts Quest was prepared to state on day one: access to patient records is believed, the scope is still under investigation, and operations are running.
Sources
- 8-K Filing — QUEST DIAGNOSTICS INC (DGX) — SEC EDGAR
- A new at-home HPV test kit is going national through Quest Diagnostics - Fast Company — fastcompany.com
- Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option – Company Announcement - FT.com — Financial Times